Browsing publications by Professor Herbie Newell

Newcastle AuthorsTitleYear
Dr Kelly Coffey
Dr Timothy Blackburn
Susan Cook
Professor Bernard Golding
Professor Roger Griffin
et al.		Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer2012
Dr Joanne Munck
Michael Batey
Dr Yan Zhao
Dr Celine Cano
Dr Michele Tavecchio
et al.		Chemosensitisation of cancer cells by KU-0060648; a dual inhibitor of DNA-PK and PI-3K2012
Dr Michele Tavecchio
Dr Joanne Munck
Dr Celine Cano
Professor Herbie Newell
Professor Nicola Curtin
et al.		Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination2012
Sari Alhasan
Dr Gary Beale
Professor Herbie Newell
Dr Helen Reeves
Suppression of SULF2, an extracellular endosulfatase up-regulated in hepatocellular cancers, modulates WNT signalling and inhibits cell growth2012
Emma Haagensen
Suzanne Kyle
Dr Gary Beale
Dr Ross Maxwell
Professor Herbie Newell
et al.		The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition2012
Michael Batey
Dr Yan Zhao
Dr Helen Maitland
Professor Hing Leung
Professor Andy Hall
et al.		Comparative pre-clinical evaluation of receptor tyrosine kinase inhibitors for the treatment of multiple myeloma2011
Huw Thomas
Professor Herbie Newell
Professor Nicola Curtin
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition2011
Dr Ian Hardcastle
Alex Liu
Dr Eric Valeur
Anna Watson
Shafiq Ahmed
et al.		Isoindolinone Inhibitors of the Murine Double Minute 2 (MDM2)-p53 Protein-Protein Interaction: Structure-ActivityStudies Leading to Improved Potency2011
Dr Karim Bennaceur
Dr Catherine Drummond
Professor Jane Endicott
Professor Bernard Golding
Professor Roger Griffin
et al.		MDM2-p53 protein-protein interaction inhibitors: A-ring substituted isoindolinones2011
Dr Kappusamy Saravanan
Hannah Barlow
Marion Barton
Professor Hilary Calvert
Professor Bernard Golding
et al.		Nucleoside Transport Inhibitors: Structure-Activity Relationships for Pyrimido[5,4-d]pyrimidine Derivatives That Potentiate Pemetrexed Cytotoxicity in the Presence of alpha(1)-Acid Glycoprotein2011
1234567891011121314151617181920...